on tirzepatide and not losing weight Why Am I Tirzepatide? Tirzepatide Weight Loss Plateau: Why

Important Precautions for Safe Use 13.1 Monitoring Blood Glucose and HbA1c Levels Routine monitoring is essential

If you are not seeing at least 5% loss by this point, something needs adjustment

Risk Factors for Lumigan-Related Eye Color Changes Lumigan (bimatoprost) can cause gradual eye color changes, particularly in individuals with lighter eye shades such as blue, green, or gray

What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation

[8] and [10]-Gingerol reduces urothelial damage in ifosfamide-induced hemorrhagic cystitis via JAK/STAT/FOXO signaling pathway via IL-10